citrulline has been researched along with Inflammatory Bowel Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, JM; Flavell, RA; Oh, J; Wei, Z | 1 |
| Andersen, V; Bennike, T; Birkelund, S; Stensballe, A | 1 |
| Abrantes, FA; Andrade, ME; Araújo, RS; Cardoso, VN; de Barros, PA; Fernandes, SO; Generoso, Sde V; Soares, AD | 1 |
| Cave, MC; Frazier, TH; Hurt, RT; McClave, SA | 1 |
| Al-Attiyah, R; Al-Azmi, W; Al-Fadli, A; Al-Jarallah, K; Ghosh, S; Panaccione, R; Shehab, D; Zafar Haider, M | 1 |
| Baeten, D; Boots, AM; De Keyser, F; De Rycke, L; Kruithof, E; Mielants, H; Veys, EM | 1 |
| af Klint, E; Catrina, AI; Klareskog, L; Löfberg, R; Lundberg, IE; Makrygiannakis, D; Ulfgren, AK | 1 |
| Fiorini, E; Forbes, A; Kalantzis, C; Papadia, C; Sherwood, RA; Volta, U; Wallis, K | 1 |
3 review(s) available for citrulline and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
Topics: Apoptosis; Biomarkers; Citrulline; Colitis, Ulcerative; Crohn Disease; Feces; Humans; Inflammatory Bowel Diseases; Mass Spectrometry; Protein Processing, Post-Translational; Proteomics; Treatment Outcome | 2014 |
The role of immunomodulators on intestinal barrier homeostasis in experimental models.
Topics: Animals; Arginine; Bifidobacterium; Citrulline; Disease Models, Animal; Epithelial Cells; Fatty Acids, Omega-3; Glutamine; Homeostasis; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactobacillus; Linoleic Acids, Conjugated; Permeability; Probiotics; Saccharomyces; Tryptophan | 2015 |
Pharmaconutrition for the obese, critically ill patient.
Topics: Antioxidants; Arginine; Citrulline; Critical Care; Critical Illness; Dietary Proteins; Dietary Supplements; Enteral Nutrition; Fatty Acids, Unsaturated; Humans; Inflammatory Bowel Diseases; Intensive Care Units; Length of Stay; Leucine; Magnesium; Obesity; Oxidative Stress; Prebiotics; Probiotics; Treatment Outcome; United States; Ventilation; Zinc | 2011 |
5 other study(ies) available for citrulline and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages.
Topics: Animals; Arthritis; Citrulline; Cyanates; Humans; Inflammation; Inflammatory Bowel Diseases; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Nitric Oxide Synthase Type II; Ornithine; Ornithine Decarboxylase; Polyamines; Salmonella typhimurium | 2022 |
Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
Topics: Adult; Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Case-Control Studies; Citrulline; Female; Humans; Inflammatory Bowel Diseases; Male; Mutation; Peptides, Cyclic; Prognosis; Vimentin; Young Adult | 2012 |
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation; Antigens, Differentiation, Myelomonocytic; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; Biopsy, Needle; Blood Sedimentation; C-Reactive Protein; Citrulline; Cluster Analysis; Cohort Studies; Female; Humans; Hyperplasia; Inflammatory Bowel Diseases; Knee Joint; Macrophages; Male; Middle Aged; Neutrophils; Phenotype; Receptors, Cell Surface; Severity of Illness Index; Spondylarthropathies; Spondylitis, Ankylosing; Synovial Membrane; Synovitis | 2005 |
Citrullination is an inflammation-dependent process.
Topics: Arthritis, Rheumatoid; Biopsy; Citrulline; Humans; Inflammatory Bowel Diseases; Muscle, Skeletal; Polymyositis; Statistics, Nonparametric; Synovial Membrane | 2006 |
Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chromatography, High Pressure Liquid; Citrulline; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Lactulose; Laparotomy; Leukocyte Count; Male; Middle Aged; Platelet Count; Prognosis; Retrospective Studies; Rhamnose; ROC Curve; Severity of Illness Index; Xylose | 2007 |